Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma is a research paper published in Drug Discovery Today (2021). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P30 CA072720
National Institutes of Health
Grant: R01 DK124897
National Institutes of Health
Grant: R01 GM133198
NCI NIH HHS
Grant: R01 CA280177
NCI NIH HHS
Grant: R01 CA260006
NCI NIH HHS
Grant: R01 CA123391
FWCI
2.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study
Additional file 1 of Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study